Monoclonal antibodies directed to the erbB-2 receptor inhibit in vivo tumour cell growth (original) (raw)
- Experimental Oncology
- Published: 01 December 1993
British Journal of Cancer volume 68, pages 1140–1145 (1993)Cite this article
- 279 Accesses
- 115 Citations
- 3 Altmetric
- Metrics details
Abstract
Four monoclonal antibodies (MAbs) specific for the extracellular domain of the human erbB-2/HER2 protein (FRP5, FSP16, FWP51 and FSP77) have been isolated (Harwerth et al., J. Biol. Chem., 267, 15160-15167, 1992). In this paper we describe the effects of erbB-2 specific MAb administration on the tumorigenic growth of human erbB-2 transformed NIH3T3 cells implanted into athymic nude mice. Two antibodies, FWP51 and FSP77, inhibited the onset of tumour growth, while the administration of FRP5 and FSP16 did not affect tumour growth. In addition, administration of MAbs FWP51 and FSP77 led to a retardation in the growth of established tumours. Treatment was not curative in that tumours regrew within two weeks of the final treatment. The administration of a combination of MAbs FWP51 and FSP77 which react with two distinct regions on the erbB-2 molecule was more effective than treatment with either MAb alone. The two growth-inhibitory antibodies were also effective in the treatment of tumours established from SKOV3 cells, a human ovarian tumour cell line with high levels of the erbB-2 protein. The effect of the MAbs on the anchorage-independent growth of erbB-2 transformed cells and on erbB-2 receptor turnover was also measured.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Similar content being viewed by others
Author information
Authors and Affiliations
- Friedrich Miescher Institute, Basel, Switzerland
I-M Harwerth
Authors
- I-M Harwerth
You can also search for this author inPubMed Google Scholar - W Wels
You can also search for this author inPubMed Google Scholar - J Schlegel
You can also search for this author inPubMed Google Scholar - M Müller
You can also search for this author inPubMed Google Scholar - NE Hynes
You can also search for this author inPubMed Google Scholar
Rights and permissions
About this article
Cite this article
Harwerth, IM., Wels, W., Schlegel, J. et al. Monoclonal antibodies directed to the _erb_B-2 receptor inhibit in vivo tumour cell growth.Br J Cancer 68, 1140–1145 (1993). https://doi.org/10.1038/bjc.1993.494
- Issue Date: 01 December 1993
- DOI: https://doi.org/10.1038/bjc.1993.494